Literature DB >> 20298536

In vivo MRI assessment of permanent middle cerebral artery occlusion by electrocoagulation: pitfalls of procedure.

Fabien Chauveau1, Samir Moucharrafie2, Marlène Wiart1, Jean-Christophe Brisset1, Yves Berthezène1, Norbert Nighoghossian1,2, Tae-Hee Cho2.   

Abstract

Permanent middle cerebral artery (MCA) occlusion (pMCAO) by electrocoagulation is a commonly used model but with potential traumatic lesions. Early MRI monitoring may assess pMCAO for non-specific brain damage. The surgical steps of pMCAO were evaluated for traumatic cerebral injury in 22 Swiss mice using diffusion and T2-weighted MRI (7T) performed within 1 h and 24 h after surgery. Temporal muscle cauterization without MCA occlusion produced an early T2 hyperintensity mimicking an infarct. No lesion was visible after temporal muscle incision or craniotomy. Early MRI monitoring is useful to identify non-specific brain injury that could hamper neuroprotective drugs assessment.

Entities:  

Year:  2010        PMID: 20298536      PMCID: PMC2827391          DOI: 10.1186/2040-7378-2-4

Source DB:  PubMed          Journal:  Exp Transl Stroke Med        ISSN: 2040-7378


Introduction

Investigating cerebral ischemia requires animal models relevant to human stroke. A precise knowledge of the strengths and shortcomings of available models is mandatory for effective research in neuroprotection [1,2]. Initially described in the rat [3] and subsequently adapted in mice [4], permanent middle cerebral artery (MCA) occlusion (pMCAO) by electrocoagulation is a widely used model of focal ischemia. Invasive surgical procedures are required: temporal muscle dissection, in some cases by electrical cauterization [5,6], subtemporal craniotomy and MCA electrocoagulation. This model, by interrupting blood flow at the level of the parietal cerebral artery branch of the MCA (distal occlusion), has the advantage of producing smaller, cortical-restricted, more reproducible and better-tolerated infarcts compared to suture MCAO, which endoluminal occluder is situated in the internal artery, at the birth of the MCA (proximal occlusion) and gives rise to extensive cortico-striatal infarcts [7,8]. It may however induce traumatic brain damage. To our knowledge, sham-operated animals have only been studied using immunohistology at the subacute stage of cerebral ischemia. Early monitoring with magnetic resonance imaging (MRI) may facilitate in vivo identification of traumatic brain injury during pMCAO.

Materials and methods

Animals and surgical procedure

We designed an analytic appraisal of pMCAO procedure which included two methods of temporal muscle dissection: cauterization and blade incision. After intraperitoneal anesthesia with 12 mg/Kg xylazine and 90 mg/Kg ketamine, 22 male Swiss mice (28-30 g, Charles River, France) were allotted as follows: • group A (n = 6): temporal muscle cauterization without craniotomy nor MCA occlusion; • group B (n = 4): temporal muscle incision without craniotomy nor MCA occlusion; • group C (n = 4): temporal muscle incision followed by craniotomy without MCA occlusion; • group D (n = 6): temporal muscle incision followed by craniotomy and MCA electrocoagulation; • group E (n = 2): temporal muscle cauterization followed by craniotomy and MCA electrocoagulation. Craniotomy and MCA electrocoagulation were performed as previously described [9]. Whatever the group be, surgery was performed in less than 15 min.

MRI

MRI experiments were performed on a 7T/12 cm magnet (Bruker BioSpin GmbH, Ettlingen, Germany) using a 72 mm inner diameter birdcage for RF transmission and a 15 mm diameter surface coil for reception. T2-weighted images (T2WI) were acquired using a RARE sequence with TE/TR = 75/3000 ms. Diffusion weighted spin-echo images (DWI) were acquired with a TE/TR = 14/2000 ms using 2 b-values (139 and 1061 s/mm2). Apparent diffusion coefficients (ADC, in mm2/s) were calculated by fitting a monoexponential model function on a pixel-by-pixel basis. The field of view was 20 × 20 mm2 and slice thickness 1.0 mm. For T2WI, 15 slices were acquired with 256 × 256 matrix and for DWI, 7 slices with 128 × 128 matrix. Mice anesthesia was maintained during the MRI with isofluorane (1.5% in air). Body temperature was kept at 37 ± 1°C with an integrated heating system, and a pressure probe monitored mice respiration. MRI was started immediately following the end of surgical procedure and all MR acquisitions were performed between 30 min and 60 min after the start of surgery. MRI was repeated on day 1.

Results

Temporal muscle cauterization in the absence of MCA electrocoagulation (group A) consistently produced an extensive lesion across the frontoparietal cortex (n = 6/6). These lesions appeared hyperintense on T2WI within the first hour after surgery, with an early mass effect and reduced ADC (Figure 1A). Temporal muscle incision and craniotomy in the absence of MCA electrocoagulation (group B and C, respectively) caused no visible brain injury on day 0 or day 1 MRI (n = 4/4 in groups B and C, Figure 1B and 1C). MCA electrocoagulation (group D) induced an ischemic lesion in the frontoparietal cortex with reduced ADC on day 0 (n = 6/6). These lesions were not visible on T2WI within 1 h post-surgery (Figure 1D). No bleeding was noted during the surgery, but MCA electrocoagulation occasionally produced a small superficial traumatic lesion (n = 2/6 in group D, figure 1D). When pMCAO was performed using temporal muscle cauterization (group E), the lesion appeared as a superimposition of the almond-shaped cauterization lesion and of the MCA-territory bounded ischemic lesion (n = 2/2, Figure 2). Infarcts from group A, D and E were clearly delineated on day 1 T2WI.
Figure 1

MRI within one hour of surgery: T. A: temporal muscle cauterization alone (group A). Note the lesion with early T2WI hyperintensity and reduced ADC (arrows). B: temporal muscle incision alone (group B). C: temporal muscle incision and craniotomy (group C). D: temporal muscle incision, craniotomy and MCA electrocoagulation. Note the ischemic lesion with low ADC (arrow) and normal T2WI with a limited superficial traumatic lesion (arrow).

Figure 2

Impact of temporal muscle cauterization on pMCAO with T. A: temporal muscle cauterization alone (group A) showing day 0 traumatic lesion (interrupted lines). B: temporal muscle cauterization, craniotomy and MCA electrocoagulation (group E). Color-coded magnification shows the boundaries of the ischemic lesion (dotted line) and traumatic lesion (interrupted lines) 6 h after pMCAO. C: same mice at day 1 showing the limits of the final lesion (dotted line).

MRI within one hour of surgery: T. A: temporal muscle cauterization alone (group A). Note the lesion with early T2WI hyperintensity and reduced ADC (arrows). B: temporal muscle incision alone (group B). C: temporal muscle incision and craniotomy (group C). D: temporal muscle incision, craniotomy and MCA electrocoagulation. Note the ischemic lesion with low ADC (arrow) and normal T2WI with a limited superficial traumatic lesion (arrow). Impact of temporal muscle cauterization on pMCAO with T. A: temporal muscle cauterization alone (group A) showing day 0 traumatic lesion (interrupted lines). B: temporal muscle cauterization, craniotomy and MCA electrocoagulation (group E). Color-coded magnification shows the boundaries of the ischemic lesion (dotted line) and traumatic lesion (interrupted lines) 6 h after pMCAO. C: same mice at day 1 showing the limits of the final lesion (dotted line).

Discussion

Our results showed that temporal muscle cauterization in the absence of ischemic stimulus produced a hyperintense area on T2WI highly suggestive of traumatic injury. Indeed, T2 increase is not expected in ischemic lesions within the first hours of occlusion in adults, although early T2 increase has been reported in neonates after MCA electrocoagulation [10] or hypoxia-ischaemia [11]. Early mass effect is uncommon after ischaemia in the adult rat [12] or mouse [13]. Acute ADC decrease is not specific of ischemic insult and has been described in both experimental and human traumatic brain injury [14,15]. Signal suggestive of intra- or extra-cranial surgery-related bleeding (T2 hypointensity) would have been ascertained using T2*WI, but were not noted. No traumatic injury was observed after temporal muscle incision. Accordingly, incision should be preferred over cauterization for temporal muscle dissection. The MRI appearance of lesions resulting from both temporal muscle cauterization (traumatic damage) and occlusion (ischemic damage) may mimic an infarction, especially if imaging is done at later time points. Histopathological analyses are usually performed after a delay of 24-72 h, when traumatic and ischemic damage may not be discernable, while early histological examination of intracerebral coagulation necrosis would be required to ascertain the thermal origin of traumatic damage induced by muscle cauterization. In the last decade, high resolution MRI has become a valuable tool for monitoring tissue damage in rodent models of cerebral ischemia. Early MRI monitoring may help to identify non-specific brain injury that could hamper neuroprotective drugs assessment.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

FC carried out the MRI experiments, participated in the design of the study and helped to draft the manuscript. SM carried out surgery. MW designed and optimized the MRI acquisition protocol, and helped to draft the manuscript. JCB participated in the MRI experiments. YB and NN conceived the study, and participated in its design and coordination. THC conceived the study, participated in its design, performed image analysis, and drafted the manuscript. All authors read and approved the final manuscript.
  15 in total

1.  MRI analysis of the changes in apparent water diffusion coefficient, T(2) relaxation time, and cerebral blood flow and volume in the temporal evolution of cerebral infarction following permanent middle cerebral artery occlusion in rats.

Authors:  M Rudin; D Baumann; D Ekatodramis; R Stirnimann; K H McAllister; A Sauter
Journal:  Exp Neurol       Date:  2001-05       Impact factor: 5.330

2.  RODENT STROKE MODEL GUIDELINES FOR PRECLINICAL STROKE TRIALS (1ST EDITION).

Authors:  Shimin Liu; Gehua Zhen; Bruno P Meloni; Kym Campbell; H Richard Winn
Journal:  J Exp Stroke Transl Med       Date:  2009-01-01

3.  IKK mediates ischemia-induced neuronal death.

Authors:  Oliver Herrmann; Bernd Baumann; Rossana de Lorenzi; Sajjad Muhammad; Wen Zhang; Jens Kleesiek; Max Malfertheiner; Martin Köhrmann; Ioana Potrovita; Ira Maegele; Cordian Beyer; James R Burke; Mazahir T Hasan; Hermann Bujard; Thomas Wirth; Manolis Pasparakis; Markus Schwaninger
Journal:  Nat Med       Date:  2005-11-13       Impact factor: 53.440

4.  Early T1- and T2-weighted MRI signatures of transient and permanent middle cerebral artery occlusion in a murine stroke model studied at 9.4T.

Authors:  Philip A Barber; Lisa Hoyte; David Kirk; Tad Foniok; Alastair Buchan; Ursula Tuor
Journal:  Neurosci Lett       Date:  2005-11-04       Impact factor: 3.046

5.  Predominance of cellular edema in traumatic brain swelling in patients with severe head injuries.

Authors:  Anthony Marmarou; Stefano Signoretti; Panos P Fatouros; Gina Portella; Gunes A Aygok; M Ross Bullock
Journal:  J Neurosurg       Date:  2006-05       Impact factor: 5.115

Review 6.  Rodent models of focal stroke: size, mechanism, and purpose.

Authors:  S Thomas Carmichael
Journal:  NeuroRx       Date:  2005-07

7.  Effect of the reperfusion after cerebral ischemia in neonatal rats using MRI monitoring.

Authors:  Sebastien Fau; Chrystelle Po; Brigitte Gillet; Stephane Sizonenko; Jean Mariani; Philippe Meric; Christiane Charriaut-Marlangue
Journal:  Exp Neurol       Date:  2007-09-15       Impact factor: 5.330

8.  Development of acute edema following cerebral hypoxia-ischemia in neonatal compared with juvenile rats using magnetic resonance imaging.

Authors:  Min Qiao; Peter Latta; Shuzhen Meng; Boguslaw Tomanek; Ursula I Tuor
Journal:  Pediatr Res       Date:  2003-11-06       Impact factor: 3.756

Review 9.  Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia.

Authors:  Aysan Durukan; Turgut Tatlisumak
Journal:  Pharmacol Biochem Behav       Date:  2007-05-04       Impact factor: 3.533

Review 10.  Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions.

Authors:  David J Gladstone; Sandra E Black; Antoine M Hakim
Journal:  Stroke       Date:  2002-08       Impact factor: 7.914

View more
  7 in total

Review 1.  Nanotheragnostic applications for ischemic and hemorrhagic strokes: improved delivery for a better prognosis.

Authors:  Tarek H Mouhieddine; Muhieddine M Itani; Amaly Nokkari; Changhong Ren; Georges Daoud; Asad Zeidan; Stefania Mondello; Firas H Kobeissy
Journal:  Curr Neurol Neurosci Rep       Date:  2015-01       Impact factor: 5.081

2.  Synchrotron radiation X-ray phase micro-computed tomography as a new method to detect iron oxide nanoparticles in the brain.

Authors:  M Marinescu; M Langer; A Durand; C Olivier; A Chabrol; H Rositi; F Chauveau; T H Cho; N Nighoghossian; Y Berthezène; F Peyrin; M Wiart
Journal:  Mol Imaging Biol       Date:  2013-10       Impact factor: 3.488

3.  Brain virtual histology with X-ray phase-contrast tomography Part I: whole-brain myelin mapping in white-matter injury models.

Authors:  Matthieu Chourrout; Hugo Rositi; Elodie Ong; Violaine Hubert; Alexandre Paccalet; Louis Foucault; Awen Autret; Barbara Fayard; Cécile Olivier; Radu Bolbos; Françoise Peyrin; Claire Crola-da-Silva; David Meyronet; Olivier Raineteau; Héléne Elleaume; Emmanuel Brun; Fabien Chauveau; Marlene Wiart
Journal:  Biomed Opt Express       Date:  2022-02-23       Impact factor: 3.732

4.  Spatial and temporal MRI profile of ischemic tissue after the acute stages of a permanent mouse model of stroke.

Authors:  A Bogaert-Buchmann; M Poittevin; C Po; D Dupont; C Sebrié; Y Tomita; A Trandinh; J Seylaz; E Pinard; P Méric; N Kubis; B Gillet
Journal:  Open Neuroimag J       Date:  2013-02-01

5.  Monitoring therapeutic effects in experimental stroke by serial USPIO-enhanced MRI.

Authors:  Marilena Marinescu; Fabien Chauveau; Anne Durand; Adrien Riou; Tae-Hee Cho; Anne Dencausse; Sébastien Ballet; Norbert Nighoghossian; Yves Berthezène; Marlène Wiart
Journal:  Eur Radiol       Date:  2012-07-26       Impact factor: 5.315

6.  In vivo layer visualization of rat olfactory bulb by a swept source optical coherence tomography and its confirmation through electrocoagulation and anatomy.

Authors:  Hideyuki Watanabe; Uma Maheswari Rajagopalan; Yu Nakamichi; Kei M Igarashi; Violeta Dimitrova Madjarova; Hirofumi Kadono; Manabu Tanifuji
Journal:  Biomed Opt Express       Date:  2011-07-15       Impact factor: 3.732

7.  Granulocyte colony-stimulating factor increases the therapeutic efficacy of bone marrow mononuclear cell transplantation in cerebral ischemia in mice.

Authors:  Xue-Mei Zhang; Fang Du; Dan Yang; Rui Wang; Chun-Jiang Yu; Xiang-Nan Huang; Hong-Yan Hu; Wei Liu; Jin Fu
Journal:  BMC Neurosci       Date:  2011-06-24       Impact factor: 3.288

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.